These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36281488)

  • 1. The Possible Impact of Nationwide Vaccination on Outcomes of the COVID-19 Epidemic in North Korea: A Modelling Study.
    Jung SM; Jung J
    J Korean Med Sci; 2022 Oct; 37(41):e300. PubMed ID: 36281488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model-informed COVID-19 exit strategy with projections of SARS-CoV-2 infections generated by variants in the Republic of Korea.
    Jung SM; Huh K; Radnaabaatar M; Jung J
    BMC Public Health; 2022 Nov; 22(1):2098. PubMed ID: 36384532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. North Korean health at risk due to border closures.
    Devi S
    Lancet; 2021 Jul; 398(10294):13. PubMed ID: 34217383
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to COVID-19 during the Tokyo Olympic Games: Did we properly assess the risk?
    Jung SM; Hayashi K; Kayano T; Nishiura H
    Epidemics; 2022 Sep; 40():100618. PubMed ID: 35908478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of national lockdown on the suspected SARS-CoV-2 epidemic in terms of the number of fever cases in North Korea.
    Han C; Ryu S; Shin H; Kim D; Modchang C
    J Travel Med; 2022 Sep; 29(6):. PubMed ID: 35899877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria Incidence of the Regions Adjacent to the Demilitarized Zone in the Democratic People's Republic of Korea, 2004-2016.
    Kim JH; Lim AY; Cheong HK
    J Korean Med Sci; 2019 Sep; 34(36):e227. PubMed ID: 31538416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Social Distancing Policy for COVID-19 Control in Korea: A Model-Based Analysis.
    Jo Y; Shrestha S; Radnaabaatar M; Park H; Jung J
    J Korean Med Sci; 2022 Jun; 37(23):e189. PubMed ID: 35698839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of the COVID-19 epidemic in the post-vaccination period in Korea: a rapid assessment.
    Min KD; Tak S
    Epidemiol Health; 2021; 43():e2021040. PubMed ID: 34082498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fighting Hepatitis B in North Korea: Feasibility of a Bi-modal Prevention Strategy.
    Unnewehr M; Stich A
    J Korean Med Sci; 2015 Nov; 30(11):1584-8. PubMed ID: 26539001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the Impact of SARS-CoV-2 Variants on the COVID-19 Epidemic and Social Restoration in the United States: A Mathematical Modelling Study.
    Li R; Li Y; Zou Z; Liu Y; Li X; Zhuang G; Shen M; Zhang L
    Front Public Health; 2021; 9():801763. PubMed ID: 35083192
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts.
    Tran TN; Wikle NB; Albert E; Inam H; Strong E; Brinda K; Leighow SM; Yang F; Hossain S; Pritchard JR; Chan P; Hanage WP; Hanks EM; Boni MF
    BMC Med; 2021 Jul; 19(1):162. PubMed ID: 34253200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. North Korea's COVID-19 policy dilemma: epidemic prevention conflicting with trade.
    Park B; Cho J
    Global Health; 2024 Jan; 20(1):8. PubMed ID: 38229142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
    Mattiuzzi C; Henry BM; Lippi G
    Int J Infect Dis; 2022 May; 118():167-168. PubMed ID: 35278677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Household Secondary Attack Rates of SARS-CoV-2 Omicron Variant, South Korea, February 2022.
    Lim DS; Choe YJ; Man Kim Y; Lee SE; Jang EJ; Kim J; Park YJ
    Emerg Infect Dis; 2022 Aug; 28(8):1731-1734. PubMed ID: 35798007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
    Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
    BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household.
    Yi S; Kim JM; Choe YJ; Hong S; Choi S; Ahn SB; Kim M; Park YJ
    J Korean Med Sci; 2022 Jan; 37(1):e12. PubMed ID: 34981682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health measures on COVID-19 in North Korea: a quantitative analysis of media programmes in 2020-2022.
    Kim T; Kim J; Jeon J; Moon JS
    BMJ Open; 2023 Jul; 13(7):e069492. PubMed ID: 37463820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the impact of control strategies on the tuberculosis burden in South and North Korea using a mathematical model.
    Cho H; Park Y; Seok J; Yeom JS; Choi JY; Kim HJ; Kang YA; Lee J
    BMJ Glob Health; 2021 Oct; 6(10):. PubMed ID: 34620614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. People's Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis.
    Eibensteiner F; Ritschl V; Nawaz FA; Fazel SS; Tsagkaris C; Kulnik ST; Crutzen R; Klager E; Völkl-Kernstock S; Schaden E; Kletecka-Pulker M; Willschke H; Atanasov AG
    J Med Internet Res; 2021 Apr; 23(4):e28973. PubMed ID: 33872185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical modelling of vaccination rollout and NPIs lifting on COVID-19 transmission with VOC: a case study in Toronto, Canada.
    Aruffo E; Yuan P; Tan Y; Gatov E; Moyles I; Bélair J; Watmough J; Collier S; Arino J; Zhu H
    BMC Public Health; 2022 Jul; 22(1):1349. PubMed ID: 35841012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.